September 2021

All Labs Are Threatened by Ransomware Attacks

This is an excerpt of a 1,652-word article in the September 7, 2021 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Cybercrime—in the form of encryption attacks followed by ransom demands—is now a threat to every clinical laboratory and anatomic pathology group in […]

To access this post, you must purchase The Dark Report.

All Labs Are Threatened by Ransomware Attacks Read More »

Are Live Lab Industry Conferences Returning?

Commentary and Opinion by R. Lewis Dark / R. Lewis Dark

For several months, many of you have used conversations and email to encourage us to conduct a live Executive War College before the end of 2021. It was because of this support that we arranged a hotel in a state that has supported a return to more normal activities. Thus, our conference will take place

To access this post, you must purchase The Dark Report.

Are Live Lab Industry Conferences Returning? Read More »

PathAI Buys Poplar Health, Creates Unique Company

Anatomic Pathology / Robert Michel

CEO SUMMARY: Pathologists were surprised this summer when a company developing image analysis software announced the acquisition of one of the nation’s largest independent anatomic pathology (AP) laboratories. The technology company PathAI is now the owner of Poplar Healthcare Management, in Memphis. It may turn out that this provocative combination of a pathology image analysis

To access this post, you must purchase The Dark Report.

PathAI Buys Poplar Health, Creates Unique Company Read More »

Lab Briefs

Clinical Laboratory / Robert Michel

DOJ Obtains $140 Mil. Settlement in Drug Testing Case Last Friday, the U.S. Department of Justice (DOJ) announced a settlement totaling $136,025,077 with multiple defendants accused of using illegal inducements to encourage physicians to refer urine drug tests to the defendants. The judgement was issued by the U.S. District Court for the District of South

To access this post, you must purchase The Dark Report.

Lab Briefs Read More »

NeoGenomics Acquires Inivata to Access Liquid Biopsy Technology

Clinical Laboratory / Robert Michel

SOME BELIEVE THAT LIQUID BIOPSY TECHNOLOGY has the potential to develop into a Holy Grail of cancer diagnostics. Yet progress in this field has been slow. Now a recent lab acquisition may accelerate the development of clinically-useful liquid biopsies. There is keen interest in how to achieve the noninvasive diagnosis of cancer. Investors have ploughed

To access this post, you must purchase The Dark Report.

NeoGenomics Acquires Inivata to Access Liquid Biopsy Technology Read More »

UK Hospitals to Deploy AI to Speed Prostate Cancer Diagnoses

Digital Pathology / Robert Michel

SEEKING TO SPEED UP THE PRODUCTION OF TEST RESULTS for men suspected of having prostate cancer, six hospitals in the United Kingdom (UK) will get funding to determine if artificial intelligence (AI) can diagnose prostate cancer quicker and more accurately than pathologists. Anatomic pathologists in the United States will want to watch the progress of

To access this post, you must purchase The Dark Report.

UK Hospitals to Deploy AI to Speed Prostate Cancer Diagnoses Read More »

2020 Rankings of the World’s Largest IVD Corporations

In Vitro Diagnostics / Robert Michel

IN VITRO DIAGNOSTICS (IVD) MANUFACTURING continues to be dominated by a handful of companies, all of which sell their products worldwide. As the rankings below demonstrate, for 2020, just 11 companies accounted for 82.7% of international IVD sales. The COVID-19 pandemic and the need for unprecedented numbers of SARS-CoV-2 tests—both molecular and serological—gave these IVD

To access this post, you must purchase The Dark Report.

2020 Rankings of the World’s Largest IVD Corporations Read More »

Comment Period Closing on Federal Surprise Billing Rule

Laboratory Compliance / Robert Michel

PATHOLOGY GROUPS AND CLINICAL LABS HAD UNTIL SEPTEMBER 7 to comment on an interim final rule that provides federal protections against surprise billing and limits out-of-network (OON) cost sharing under many of the circumstances in which surprise bills arise most frequently. On July 1, 2021, four federal agencies issued an interim final rule (IFR) with

To access this post, you must purchase The Dark Report.

Comment Period Closing on Federal Surprise Billing Rule Read More »

September 7, 2021 Intelligence: Late-Breaking Lab News

Late Breaking Lab News / Robert Michel

New diagnoses of cancer in the United States fell by almost 30% in the early months of the SARS-CoV-2 pandemic. That’s one conclusion in a paper authored by Quest Diagnostics and published on Aug. 31, in JAMA Network Open. Quest looked at the new diagnoses of eight common types of cancer during four periods: •

To access this post, you must purchase The Dark Report.

September 7, 2021 Intelligence: Late-Breaking Lab News Read More »